Dong-Wook Kim

Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up results

Hagop M. Kantarjian, Francis J. Giles, Kapil N. Bhalla et al. · Blood · 2010 · 379 citations

Pharmacy, Pharmacology, Pharmacotherapy +5

Validation of Recently Proposed Consensus Criteria for Thrombotic Microangiopathy After Allogeneic Hematopoietic Stem-Cell Transplantation

Byung‐Sik Cho, Seung‐Ah Yahng, Sung‐Eun Lee et al. · Transplantation · 2010 · 275 citations

Medicine, Hematology, Hematopathology +7

Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease

Susan Branford, Paul Wang, David T Yeung et al. · Blood · 2018 · 209 citations · Full text

Medicine, Genetics, Molecular Genetics +12

The effect of first-line imatinib interim therapy on the outcome of allogeneic stem cell transplantation in adults with newly diagnosed Philadelphia chromosome–positive acute lymphoblastic leukemia

Seok Lee, Yoo‐Jin Kim, Chang‐Ki Min et al. · Blood · 2005 · 195 citations · Full text

Medicine, Hematology, Oncology +12

Geriatric assessment predicts nonfatal toxicities and survival for intensively treated older adults with AML

Gi June Min, Byung‐Sik Cho, Sung‐Soo Park et al. · Blood · 2022 · 65 citations

Medicine, Geriatric Medicine, Frailty +12